These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 17487889)
21. The importance of SRS-1 residues in catalytic specificity of human cytochrome P450 3A4. Roussel F; Khan KK; Halpert JR Arch Biochem Biophys; 2000 Feb; 374(2):269-78. PubMed ID: 10666307 [TBL] [Abstract][Full Text] [Related]
22. Functional characterization of two novel CYP2C19 variants (CYP2C19*18 and CYP2C19*19) found in a Japanese population. Hanioka N; Tsuneto Y; Saito Y; Sumada T; Maekawa K; Saito K; Sawada J; Narimatsu S Xenobiotica; 2007 Apr; 37(4):342-55. PubMed ID: 17455109 [TBL] [Abstract][Full Text] [Related]
23. Pharmacogenetics and polymorphism of human P-450 which activates and detoxicates xenobiotics and carcinogens. Kato R; Yamazoe Y; Yasumori T Princess Takamatsu Symp; 1990; 21():45-53. PubMed ID: 2134689 [TBL] [Abstract][Full Text] [Related]
24. Selectivity of substrate binding and ionization of 2-methyl-3-hydroxypyridine-5-carboxylic acid oxygenase. Luanloet T; Sucharitakul J; Chaiyen P FEBS J; 2015 Aug; 282(16):3107-25. PubMed ID: 25639849 [TBL] [Abstract][Full Text] [Related]
25. Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes. Abelö A; Andersson TB; Antonsson M; Naudot AK; Skånberg I; Weidolf L Drug Metab Dispos; 2000 Aug; 28(8):966-72. PubMed ID: 10901708 [TBL] [Abstract][Full Text] [Related]
26. Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling. Spatzenegger M; Liu H; Wang Q; Debarber A; Koop DR; Halpert JR J Pharmacol Exp Ther; 2003 Jan; 304(1):477-87. PubMed ID: 12490624 [TBL] [Abstract][Full Text] [Related]
27. The role of CYP2C19 in the metabolism of (+/-) bufuralol, the prototypic substrate of CYP2D6. Mankowski DC Drug Metab Dispos; 1999 Sep; 27(9):1024-8. PubMed ID: 10460802 [TBL] [Abstract][Full Text] [Related]
28. CYP2C19 polymorphisms account for inter-individual variability of drug metabolism in cynomolgus macaques. Uno Y; Matsushita A; Shukuya M; Matsumoto Y; Murayama N; Yamazaki H Biochem Pharmacol; 2014 Sep; 91(2):242-8. PubMed ID: 25036290 [TBL] [Abstract][Full Text] [Related]
29. Influence of the CYP2C9 AND CYP2C19 polymorphisms on phenytoin hydroxylation in healthy individuals from south India. Rosemary J; Surendiran A; Rajan S; Shashindran CH; Adithan C Indian J Med Res; 2006 May; 123(5):665-70. PubMed ID: 16873909 [TBL] [Abstract][Full Text] [Related]
30. Interaction of aflatoxin B1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity. Pelkonen P; Lang MA; Negishi M; Wild CP; Juvonen RO Chem Res Toxicol; 1997 Jan; 10(1):85-90. PubMed ID: 9074807 [TBL] [Abstract][Full Text] [Related]
31. CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai population. He N; Yan FX; Huang SL; Wang W; Xiao ZS; Liu ZQ; Zhou HH Eur J Clin Pharmacol; 2002 Apr; 58(1):15-8. PubMed ID: 11956668 [TBL] [Abstract][Full Text] [Related]
32. Differential contribution of active site residues in substrate recognition sites 1 and 5 to cytochrome P450 2C8 substrate selectivity and regioselectivity. Kerdpin O; Elliot DJ; Boye SL; Birkett DJ; Yoovathaworn K; Miners JO Biochemistry; 2004 Jun; 43(24):7834-42. PubMed ID: 15196026 [TBL] [Abstract][Full Text] [Related]
33. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes. Takahashi H; Kashima T; Nomizo Y; Muramoto N; Shimizu T; Nasu K; Kubota T; Kimura S; Echizen H Clin Pharmacol Ther; 1998 May; 63(5):519-28. PubMed ID: 9630825 [TBL] [Abstract][Full Text] [Related]
34. Interactions between CYP2C9 and CYP2C19 in reconstituted binary systems influence their catalytic activity: possible rationale for the inability of CYP2C19 to catalyze methoxychlor demethylation in human liver microsomes. Hazai E; Kupfer D Drug Metab Dispos; 2005 Jan; 33(1):157-64. PubMed ID: 15486075 [TBL] [Abstract][Full Text] [Related]
35. Species differences in stereoselective metabolism of mephenytoin by cytochrome P450 (CYP2C and CYP3A). Yasumori T; Chen L; Nagata K; Yamazoe Y; Kato R J Pharmacol Exp Ther; 1993 Jan; 264(1):89-94. PubMed ID: 8423554 [TBL] [Abstract][Full Text] [Related]
36. Elucidation of amino acid residues critical for unique activities of rabbit cytochrome P450 2B5 using hybrid enzymes and reciprocal site-directed mutagenesis with rabbit cytochrome P450 2B4. Szklarz GD; He YQ; Kedzie KM; Halpert JR; Burnett VL Arch Biochem Biophys; 1996 Mar; 327(2):308-18. PubMed ID: 8619620 [TBL] [Abstract][Full Text] [Related]
37. The role of cytochrome P2C19 in R-warfarin pharmacokinetics and its interaction with omeprazole. Uno T; Sugimoto K; Sugawara K; Tateishi T Ther Drug Monit; 2008 Jun; 30(3):276-81. PubMed ID: 18520598 [TBL] [Abstract][Full Text] [Related]
38. Identification of critical amino acid residues of human CYP2A13 for the metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen. He XY; Shen J; Ding X; Lu AY; Hong JY Drug Metab Dispos; 2004 Dec; 32(12):1516-21. PubMed ID: 15333516 [TBL] [Abstract][Full Text] [Related]
39. Dual role of human cytochrome P450 3A4 residue Phe-304 in substrate specificity and cooperativity. Domanski TL; He YA; Harlow GR; Halpert JR J Pharmacol Exp Ther; 2000 May; 293(2):585-91. PubMed ID: 10773032 [TBL] [Abstract][Full Text] [Related]
40. Cynomolgus monkey cytochrome P450 2C43: cDNA cloning, heterologous expression, purification and characterization. Mitsuda M; Iwasaki M; Asahi S J Biochem; 2006 May; 139(5):865-72. PubMed ID: 16751594 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]